153 related articles for article (PubMed ID: 29603837)
1. Treatment with the GSK3-beta inhibitor Tideglusib improves hippocampal development and memory performance in juvenile, but not adult, Cdkl5 knockout mice.
Fuchs C; Fustini N; Trazzi S; Gennaccaro L; Rimondini R; Ciani E
Eur J Neurosci; 2018 May; 47(9):1054-1066. PubMed ID: 29603837
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorder.
Fuchs C; Rimondini R; Viggiano R; Trazzi S; De Franceschi M; Bartesaghi R; Ciani E
Neurobiol Dis; 2015 Oct; 82():298-310. PubMed ID: 26143616
[TBL] [Abstract][Full Text] [Related]
3. Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of
Loi M; Gennaccaro L; Fuchs C; Trazzi S; Medici G; Galvani G; Mottolese N; Tassinari M; Giorgini RR; Milelli A; Ciani E
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073043
[TBL] [Abstract][Full Text] [Related]
4. Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling.
Fuchs C; Trazzi S; Torricella R; Viggiano R; De Franceschi M; Amendola E; Gross C; Calzà L; Bartesaghi R; Ciani E
Neurobiol Dis; 2014 Oct; 70(100):53-68. PubMed ID: 24952363
[TBL] [Abstract][Full Text] [Related]
5. Loss of CDKL5 in Glutamatergic Neurons Disrupts Hippocampal Microcircuitry and Leads to Memory Impairment in Mice.
Tang S; Wang IJ; Yue C; Takano H; Terzic B; Pance K; Lee JY; Cui Y; Coulter DA; Zhou Z
J Neurosci; 2017 Aug; 37(31):7420-7437. PubMed ID: 28674172
[TBL] [Abstract][Full Text] [Related]
6. Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology.
Castano A; Silvestre M; Wells CI; Sanderson JL; Ferrer CA; Ong HW; Lang Y; Richardson W; Silvaroli JA; Bashore FM; Smith JL; Genereux IM; Dempster K; Drewry DH; Pabla NS; Bullock AN; Benke TA; Ultanir SK; Axtman AD
Elife; 2023 Jul; 12():. PubMed ID: 37490324
[TBL] [Abstract][Full Text] [Related]
7. Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder.
Mottolese N; Uguagliati B; Tassinari M; Cerchier CB; Loi M; Candini G; Rimondini R; Medici G; Trazzi S; Ciani E
Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759796
[TBL] [Abstract][Full Text] [Related]
8. CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder.
Trazzi S; De Franceschi M; Fuchs C; Bastianini S; Viggiano R; Lupori L; Mazziotti R; Medici G; Lo Martire V; Ren E; Rimondini R; Zoccoli G; Bartesaghi R; Pizzorusso T; Ciani E
Hum Mol Genet; 2018 May; 27(9):1572-1592. PubMed ID: 29474534
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive behavioral analysis of the Cdkl5 knockout mice revealed significant enhancement in anxiety- and fear-related behaviors and impairment in both acquisition and long-term retention of spatial reference memory.
Okuda K; Takao K; Watanabe A; Miyakawa T; Mizuguchi M; Tanaka T
PLoS One; 2018; 13(4):e0196587. PubMed ID: 29702698
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder.
Galvani G; Mottolese N; Gennaccaro L; Loi M; Medici G; Tassinari M; Fuchs C; Ciani E; Trazzi S
J Neuroinflammation; 2021 Jul; 18(1):155. PubMed ID: 34238328
[TBL] [Abstract][Full Text] [Related]
11. HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder.
Trazzi S; Fuchs C; Viggiano R; De Franceschi M; Valli E; Jedynak P; Hansen FK; Perini G; Rimondini R; Kurz T; Bartesaghi R; Ciani E
Hum Mol Genet; 2016 Sep; 25(18):3887-3907. PubMed ID: 27466189
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder.
Fuchs C; Gennaccaro L; Ren E; Galvani G; Trazzi S; Medici G; Loi M; Conway E; Devinsky O; Rimondini R; Ciani E
Neuropharmacology; 2020 May; 167():107746. PubMed ID: 31469994
[TBL] [Abstract][Full Text] [Related]
13. CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling.
Fuchs C; Medici G; Trazzi S; Gennaccaro L; Galvani G; Berteotti C; Ren E; Loi M; Ciani E
Brain Pathol; 2019 Sep; 29(5):658-674. PubMed ID: 30793413
[TBL] [Abstract][Full Text] [Related]
14. Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorder.
Tassinari M; Uguagliati B; Trazzi S; Cerchier CB; Cavina OV; Mottolese N; Loi M; Candini G; Medici G; Ciani E
Neurobiol Dis; 2023 Jun; 182():106146. PubMed ID: 37164289
[TBL] [Abstract][Full Text] [Related]
15. The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo.
Trovò L; Fuchs C; De Rosa R; Barbiero I; Tramarin M; Ciani E; Rusconi L; Kilstrup-Nielsen C
Neurobiol Dis; 2020 May; 138():104791. PubMed ID: 32032735
[TBL] [Abstract][Full Text] [Related]
16. Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder.
Fuchs C; Gennaccaro L; Trazzi S; Bastianini S; Bettini S; Lo Martire V; Ren E; Medici G; Zoccoli G; Rimondini R; Ciani E
Neural Plast; 2018; 2018():9726950. PubMed ID: 29977282
[TBL] [Abstract][Full Text] [Related]
17. A GABA
Gennaccaro L; Fuchs C; Loi M; Roncacè V; Trazzi S; Ait-Bali Y; Galvani G; Berardi AC; Medici G; Tassinari M; Ren E; Rimondini R; Giustetto M; Aicardi G; Ciani E
Neurobiol Dis; 2021 Jun; 153():105304. PubMed ID: 33621640
[TBL] [Abstract][Full Text] [Related]
18. Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder.
Tassinari M; Mottolese N; Galvani G; Ferrara D; Gennaccaro L; Loi M; Medici G; Candini G; Rimondini R; Ciani E; Trazzi S
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955854
[TBL] [Abstract][Full Text] [Related]
19. CDKL5 Deficiency Augments Inhibitory Input into the Dentate Gyrus That Can Be Reversed by Deep Brain Stimulation.
Hao S; Wang Q; Tang B; Wu Z; Yang T; Tang J
J Neurosci; 2021 Oct; 41(43):9031-9046. PubMed ID: 34544833
[TBL] [Abstract][Full Text] [Related]
20. Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons.
Loi M; Trazzi S; Fuchs C; Galvani G; Medici G; Gennaccaro L; Tassinari M; Ciani E
Mol Neurobiol; 2020 May; 57(5):2244-2262. PubMed ID: 32002787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
